Differences have been reported between the NSCLC subtypes adenocarcinoma and squamous cell carcinoma regarding perfusion related parameters [33] and staining of markers of hypoxia and metabolism (e.g. CAIX, GLUT-1) in pathological tumour specimens [43]. The gene discussed is CA9; the disease is adenocarcinoma.